4.6 Article

A Murine Model for Quantitative, Real-Time Evaluation of Convection-Enhanced Delivery (RT-CED) Using an 18[F]-Positron Emitting, Fluorescent Derivative of Dasatinib

期刊

MOLECULAR CANCER THERAPEUTICS
卷 16, 期 12, 页码 2902-2912

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1535-7163.MCT-17-0423

关键词

-

类别

资金

  1. National Institute of Biomedical Imaging and Bioengineering [K99/R00EB013904]
  2. Alex Lemonade Stand Foundation for Childhood Cancer
  3. Alex Lemonade Stand Foundation Pediatric Oncology Student Training Program
  4. Matthew Larson Foundation for Pediatric Brain Tumors Research Grant
  5. St. Baldrick's Summer Fellow Grant

向作者/读者索取更多资源

The blood brain barrier can limit the efficacy of systemically delivered drugs in treating neurological malignancies; therefore, alternate routes of drug administration must be considered. The Abl-kinase inhibitor, dasatinib, is modified to give compound 1 ([F-18]-1) so that F-18-positron emission tomography (PET) and fluorescent imaging can both be used to observe drug delivery to murine orthotopic glioma. In vitro Western blotting, binding studies (IC50 = 22 +/- 5 nmol/L), and cell viability assays (IC50 = 46 +/- 30 nmol/L) confirm nanomolar, in vitro effectiveness of [F-18]-1, a dasatinib derivative that is visible by F-18-PET and fluorescence. [F-18]-1 is used to image dynamic direct drug delivery via two different drug delivery techniques to orthotopic murine brainstem glioma (mBSG) bearing mice. Convection enhanced delivery (CED) delivers higher concentrations of drug to glioma-containing volumes versus systemic, tail-vein delivery. Accurate delivery and clearance data pertaining to dasatinib are observed, providing personalized information that is important in dosimetry and redosing. Cases of missed drug delivery are immediately recognized by PET/CT, allowing for prompt intervention in the case of missed delivery. (C) 2017 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysis

Umberto Tosi, Omri Maayan, Anjile An, Miguel E. Tusa Lavieri, Sergio W. Guadix, Antonio P. DeRosa, Paul J. Christos, Susan Pannullo, Philip E. Stieg, Andrew Brandmaier, Jonathan P. S. Knisely, Rohan Ramakrishna

Summary: Treatment of NF2-associated vestibular schwannomas remains challenging, as stereotactic radiosurgery results in impaired hearing and worse cranial nerve comorbidities.

JOURNAL OF NEURO-ONCOLOGY (2022)

Article Gastroenterology & Hepatology

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study

Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schoenlein, Johann von Felden, Kornelius Schulze, Henning Wege, Vincent E. Gaillard, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei-Chang Lee, Yi-Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Nicola Personeni, Tiziana Pressiani, Rohini Sharma, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato

Summary: This study confirms the reproducible safety and efficacy of AtezoBev in routine clinical practice. Patients with impaired liver function (CP-B) showed comparable tolerability to those with normal liver function (CP-A), indicating the need for prospective evaluation in this specific population.

HEPATOLOGY (2022)

Article Oncology

Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study

Claudia Angela Maria Fulgenzi, Jaekyung Cheon, Antonio D'Alessio, Naoshi Nishida, Celina Ang, Thomas U. Marron, Linda Wu, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Andrea Napolitano, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominik Bettinger, Arndt Vogel, Martin Schoenlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter R. Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G. Singal, Rohini Sharma, Alessio Cortellini, Vincent E. Gaillard, Hong Jae Chon, David James Pinato

Summary: This study confirms the reproducible safety and efficacy of atezolizumab plus bevacizumab in routine clinical practice for patients with unresectable hepatocellular carcinoma. The presence of portal vein tumor thrombosis (PVTT) and higher ALBI grade are indicators of poorer survival in patients who meet the Child-Pugh-A criteria.

EUROPEAN JOURNAL OF CANCER (2022)

Article Gastroenterology & Hepatology

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

Mathew Vithayathil, Antonio D'Alessio, Claudia A. M. Fulgenzi, Naoshi Nishida, Martin Schoenlein, Johann von Felden, Kornelius Schulze, Henning Wege, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei-Chang Lee, Yi-Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Nicola Personeni, Tiziana Pressiani, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato, Rohini Sharma

Summary: This study investigated the efficacy and safety of combination therapy with atezolizumab and bevacizumab in older patients with hepatocellular carcinoma. The results showed that there were no significant differences in treatment outcomes and safety between older and younger patients.

LIVER INTERNATIONAL (2022)

Article Oncology

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominik Bettinger, Arndt Vogel, Martin Schoenlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter R. Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G. Singal, Rohini Sharma, Alessio Cortellini, Vincent E. Gaillard, Hong Jae Chon, David J. Pinato, Celina Ang

Summary: Immunotherapy is the standard front-line therapy for advanced hepatocellular carcinoma, but many patients do not respond to it. This study evaluated the prognostic value of blood-based markers of inflammation and found that they may predict survival outcomes in patients treated with immunotherapy.

CANCERS (2022)

Article Oncology

Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors

Y. Linda Wu, Grace van Hyfte, Umut Ozbek, Marlene Reincke, Anuhya Gampa, Yehia I. Mohamed, Naoshi Nishida, Brooke Wietharn, Suneetha Amara, Pei-Chang Lee, Bernhard Scheiner, Lorenz Balcar, Matthias Pinter, Arndt Vogel, Arndt Weinmann, Anwaar Saeed, Anjana Pillai, Lorenza Rimassa, Abdul Rafeh Naqash, Mahvish Muzaffar, Yi-Hsiang Huang, Ahmed O. Kaseb, Masatoshi Kudo, David J. Pinato, Celina Ang

Summary: Beta blocker use was not associated with overall survival, progression-free survival, or objective response rate in patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors.

FRONTIERS IN ONCOLOGY (2023)

Review Clinical Neurology

Fifty years of DIPG: looking at the future with hope

Umberto Tosi, Mark Souweidane

Summary: Diffuse intrinsic pontine glioma (DIPG) is a childhood brainstem tumor with a very poor prognosis, and the available therapeutic options have been limited for many years. However, recent advances in tissue availability and our understanding of tumor biology have led to the development of new therapeutic targets and experimental treatment strategies.

CHILDS NERVOUS SYSTEM (2023)

Article Clinical Neurology

Neuroendoscopy: The State of the Art

Umberto Tosi, Sergio W. Guadix, Mark M. Souweidane

Summary: Neuroendoscopy has become a mainstay in neurosurgical practice, allowing for minimally invasive approaches. However, challenges remain in terms of hemostasis and resection of large masses. New optics have improved image quality, but open craniotomy is still commonly used. The limited utilization of neuroendoscopy presents ongoing challenges for teaching and achieving technical mastery in neurosurgery.

WORLD NEUROSURGERY (2023)

Article Clinical Neurology

The Future of Neuroendoscopy: Looking Ahead Through a Lens

Umberto Tosi, Mark M. Souweidane

Summary: Neuroendoscopy has made remarkable progress in recent decades, becoming a routine practice in neurosurgical treatment. However, the field still faces challenges and obstacles, but there are also many new directions of development.

WORLD NEUROSURGERY (2023)

Article Clinical Neurology

Neuroendoscopy: How We Got Here

Umberto Tosi, Sergio W. Guadix, Alan R. Cohen, Mark M. Souweidane

Summary: Neuro-endoscopy, originating from ancient Egyptian rituals, promises a minimally invasive approach to the brain. After initial technical obstacles, the development and transformation of neuroendoscopy continued and it has now become a widely used and reliable surgical option for various complex pathologies.

WORLD NEUROSURGERY (2023)

Article Clinical Neurology

Lateral Transorbital Endoscope-Assisted Approach to the Cavernous Sinus

Evan D. Bander, Joseph A. Carnevale, Umberto Tosi, Kyle J. Godfrey, Theodore H. Schwartz

Summary: The lateral transorbital approach (LTOA) is a minimally invasive surgical technique that provides direct access to the cavernous sinus. A retrospective study of CS lesions treated by LTOA showed successful outcomes in all six cases, with an average extent of resection of 64.6%. Improvement in preoperative cranial neuropathies was observed in half of the patients, and there were no new permanent cranial neuropathies. Only one patient had a vascular injury, which was repaired endovascularly without neurological deficits.

OPERATIVE NEUROSURGERY (2023)

Meeting Abstract Cell & Tissue Engineering

OVINE ADIPOSE DERIVED STEM CELLS AS POTENTIAL STEM CELL SOURCE FOR TENDON REPAIR

Arlette A. Haidar-Montes, Giuseppe Prencipe, Mohammad El Khatib, Annunziata Mauro, Paolo Berardinelli, Umberto Tosi, Guy Wouters, Johannes Stockl, Valentina Russo, Barbara Barboni

TISSUE ENGINEERING PART A (2023)

Article Clinical Neurology

Combined surgical repair and venous sinus stenting for patients with skull base encephaloceles secondary to dural venous sinus stenosis

Umberto Tosi, Alexander Ramos, Margherita Rampichini, George Alexiades, Srikanth Boddu, Babacar Cisse, Ashutosh Kacker, Athos Patsalides, Abtin Tabaee, Justin Schwarz, Theodore H. Schwartz, Rohan Ramakrishna

Summary: This study aimed to determine the feasibility of venous sinus stenting (VSS) as a treatment for symptoms relief and prevention of recurrence after surgical repair of skull base encephaloceles. The results showed that performing VSS within weeks of surgery can safely alleviate symptoms, resolve underlying pathology, and prevent CSF leak recurrence.

ACTA NEUROCHIRURGICA (2023)

Article Clinical Neurology

Endoscopic odontoidectomy for brainstem compression in association with posterior fossa decompression and occipitocervical fusion

Umberto Tosi, Alexandra Giantini-Larsen, Dimitrios Mathios, Ashutosh Kacker, Vijay K. Anand, Kiarash Ferdowssian, Ali Baaj, Roger Hartl, Benjamin I. Rapoport, Jeffrey P. Greenfield, Theodore H. Schwartz

Summary: This study reviewed the clinical data of a large number of patients who underwent EEO surgery and found that EEO surgery is safe and effective, improving patients' symptoms. Complications associated with posterior cervical fusion were rare.

JOURNAL OF NEUROSURGERY (2023)

Meeting Abstract Psychology, Clinical

Colloid Cyst: Underrecognized Neuropsychological Sequalae of a Neurosurgical Diagnosis

Heidi Bender, Evan Bander, Alice Gavarrete-Olvera, Julia Giambrone, Kseniya Katsman, Samer Muhareb, Kate Rosen, Amanda Sacks-Zimmerman, Madison Seger, Mark Souweudane, Umberto Tosi, David L. Yap

ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2023)

暂无数据